Your session is about to expire
← Back to Search
DBT + CBT for Insomnia for Adolescents at High Risk of Suicide
Study Summary
This trial aims to reduce teen suicide rates by testing if adding an evidence-based insomnia treatment to a suicide-focused therapy helps more than just the suicide-focused therapy alone.
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My psychiatric or sleep medication dose has been stable for over 2 months.My insomnia is significantly affected by substance use or stopping certain medications.I have a condition like bipolar disorder or epilepsy that needs careful consideration for CBTI.I have severe insomnia, scoring 9 or higher on a sleep test.I have untreated sleep apnea or a severe sleep disorder with late sleep or wake times.I am between 12 and 18 years old and have not graduated high school.
- Group 1: Dialectical Behavior Therapy + Cognitive Behavioral Therapy for Insomnia
- Group 2: Dialectical Behavior Therapy Only
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To whom does this clinical trial enrollment extend?
"To be considered for participation, individuals must have a history of suicidal ideation and self-harm behaviors while also falling within the age range of 12 to 18. The recruitment process is targeting approximately 44 people."
Is the research group still accepting new participants?
"Sadly, clinicaltrials.gov reports that this particular trial is not actively recruiting at present. It was first posted on December 1st 2023 and the latest update happened in May of 2023. On a brighter note, 204 other trials are accepting patients currently."
Is the age limit for this trial restricted to those above 35 years of age?
"Patients aged between 12 and 18 years old are eligible for enrolment in this trial."
Share this study with friends
Copy Link
Messenger